Neurosurgeon at “Roberto Rodriguez” General Teaching Hospital, Cubađź“–
Dr. Angel Jesus Lacerda Gallardo is a distinguished Cuban neurosurgeon, educator, and researcher with over three decades of experience in cerebrovascular microsurgery, intracranial tumor surgery, head trauma, and neuroendoscopy. As a Doctor of Medical Sciences, Titular Professor, and Principal Investigator, he has significantly contributed to advancing neurosurgical practices in Cuba and beyond. He is an Honorary Member of the Cuban Academy of Sciences and a respected figure in global neurosurgical and neurotrauma research. Dr. Lacerda is affiliated with the “Roberto RodrĂguez” General Teaching Hospital, MorĂłn, where he leads numerous clinical and academic initiatives.
Profile
Scopus Profile
Orcid Profile
Google Scholar Profile
Education Background🎓
Dr. Lacerda earned his medical degree in 1995, specializing in neurosurgery, and subsequently completed a diploma in Adult Intensive Care in 2005. In 2009, he achieved his Doctorate in Medical Sciences. Over the years, he has pursued advanced training and subspecialties in cerebrovascular microsurgery, spinal microsurgery, neuroendoscopy, and the management of intracranial tumors. His dedication to medical education has earned him the title of Titular Professor and a pivotal role in academic and doctoral committees.
Professional Experience🌱
Dr. Lacerda has served as the Head of the Neurosurgery Department at the “Roberto RodrĂguez” Hospital, where he introduced advanced techniques, including neuroendoscopy, and significantly improved service efficiency and surgical performance. He has been instrumental in establishing clinical guidelines, expanding surgical capabilities, and fostering a culture of academic excellence within the neurosurgery team. His administrative roles include organizing national and international neurology and neurosurgery symposiums and holding leadership positions in scientific and technical advisory councils.
Dr. Lacerda’s research interests focus on cerebrovascular neurosurgery, neurotrauma, intracranial tumor management, spinal microsurgery, and neuroendoscopy. He actively explores innovations in minimally invasive techniques and has contributed to clinical trials such as the CRASH Trial and PRINCE I & II. His work also emphasizes improving outcomes in severe head injuries and advancing neurosurgical care practices.
Author Metrics
Publications Top Notes đź“„
1. Predicting Outcome after Traumatic Brain Injury: Practical Prognostic Models Based on a Large Cohort of International Patients
- Authors: MRCCT Collaborators
- Journal: BMJ
- Year: 2008
- Volume and Issue: 336 (7641)
- Pages: 425-429
- Citations: 1372
2. Effect of Intravenous Corticosteroids on Death within 14 Days in 10008 Adults with Clinically Significant Head Injury (MRC CRASH Trial): Randomised Placebo-Controlled Trial
- Authors: C Trial Collaborators
- Journal: The Lancet
- Year: 2004
- Volume and Issue: 364 (9442)
- Pages: 1321-1328
- Citations: 1343
3. Final Results of MRC CRASH, a Randomised Placebo-Controlled Trial of Intravenous Corticosteroid in Adults with Head Injury—Outcomes at 6 Months
- Authors: CRASH Trial Collaborators
- Journal: The Lancet
- Year: 2005
- Volume and Issue: 365 (9475)
- Pages: 1957-1959
- Citations: 985
4. Patient Outcome after Traumatic Brain Injury in High-, Middle-, and Low-Income Countries: Analysis of Data on 8927 Patients in 46 Countries
- Authors: PV De Silva MJ, Roberts I, Perel P, Edwards P, Kenward MG, Fernandes J, Shakur H
- Journal: International Journal of Epidemiology
- Year: 2009
- Volume and Issue: 38 (2)
- Pages: 452-458
- Citations: 353
5. Global Survey of Outcomes of Neurocritical Care Patients: Analysis of the PRINCE Study Part 2
- Authors:
- Journal: Neurocritical Care
- Year: 2020
- Volume and Issue: 32 (1)
- Pages: 88-103
- Citations: 69
Conclusion